Literature DB >> 11441095

Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body.

M van Lith1, M van Ham, A Griekspoor, E Tjin, D Verwoerd, J Calafat, H Janssen, E Reits, L Pastoors, J Neefjes.   

Abstract

MHC class II molecules bind antigenic peptides in the late endosomal/lysosomal MHC class II compartments (MIIC) before cell surface presentation. The class II modulatory molecules HLA-DM and HLA-DO mainly localize to the MIICs. Here we show that DM/DO complexes continuously recycle between the plasma membrane and the lysosomal MIICs. Like DMbeta and the class II-associated invariant chain, the DObeta cytoplasmic tail contains potential lysosomal targeting signals. The DObeta signals, however, are not essential for internalization of the DM/DO complex from the plasma membrane or targeting to the MIICs. Instead, the DObeta tail determines the distribution of both DM/DO and class II within the multivesicular MIIC by preferentially localizing them to the limiting membrane and, in lesser amounts, to the internal membranes. This distribution augments the efficiency of class II antigenic peptide loading by affecting the efficacy of lateral interaction between DM/DO and class II molecules. Sorting of DM/DO and class II molecules to specific localizations within the MIIC represents a novel way of regulating MHC class II Ag presentation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441095     DOI: 10.4049/jimmunol.167.2.884

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infection.

Authors:  Daniëlle Horst; Wim P Burmeister; Ingrid G J Boer; Daphne van Leeuwen; Marlyse Buisson; Alexander E Gorbalenya; Emmanuel J H J Wiertz; Maaike E Ressing
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

3.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

4.  Sibling rivalry: competition between MHC class II family members inhibits immunity.

Authors:  Lisa K Denzin; Peter Cresswell
Journal:  Nat Struct Mol Biol       Date:  2013-01       Impact factor: 15.369

5.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.

Authors:  Taejin Yoon; Henriette Macmillan; Sarah E Mortimer; Wei Jiang; Cornelia H Rinderknecht; Lawrence J Stern; Elizabeth D Mellins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 6.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

7.  Alternative splicing of major histocompatibility complex class II DXB transcripts in Xiphophorus fishes.

Authors:  Kelly E Roney; Brandon J Cuthbertson; Ulla B Godwin; Steven Kazianis; Luis Della Coletta; Gil G Rosenthal; Michael J Ryan; Margit Schmidt; Thomas J McConnell
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

8.  Ubiquitination of HLA-DO by MARCH family E3 ligases.

Authors:  Martin Jahnke; John Trowsdale; Adrian P Kelly
Journal:  Eur J Immunol       Date:  2013-03-11       Impact factor: 5.532

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  The HLA-DRalpha chain is modified by polyubiquitination.

Authors:  Nicolas Lapaque; Martin Jahnke; John Trowsdale; Adrian P Kelly
Journal:  J Biol Chem       Date:  2008-12-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.